|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/22 | |
| C07K 14/745 | |||
| C12N 9/64 |
| (11) | Patento numeris | 2526115 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11700547.0 |
| Europos patento paraiškos padavimo data | 2011-01-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/050594 |
| Data | 2011-01-18 |
| (87) | Numeris | WO 2011/086197 |
| Data | 2011-07-21 |
| (30) | Numeris | Data | Šalis |
| 297011 P | 2010-01-21 | US | |
| 10150980 | 2010-01-18 | EP |
| (72) |
BJELKE, Jais, Rose, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | PURIFICATION OF BLOOD COAGULATION FACTORS |
| PURIFICATION OF BLOOD COAGULATION FACTORS |